Publication | Open Access

Comorbidity, age and overall survival in cetuximab-treated patients with advanced colorectal cancer (ACRC)—results from NCIC CTG CO.17: a phase III trial of cetuximab versus best supportive care

Gastrointestinal OncologyNcic Ctg Co.17MedicineCancer ManagementPhase Iii TrialColorectal CancerPathologyCancer TreatmentAdvanced Colorectal CancerOncologyRadiation Oncology